Hospital Universitario Mutua de Terrassa

Terrassa, Barcelona 08221

2 studies enrolling now · 6 studies all time

What they study most

C. Diff Infection, C.Difficile Diarrhea, CDI, Candidemia, Clostridioides Difficile Infection, Clostridioides Difficile Infection Recurrence, Clostridium Difficile, Clostridium Difficile Infection Recurrence, Clostridium Difficile Infections, Complicated Intra-abdominal Infection, Diarrhea Infectious, First Line Non-Small Cell Lung Cancer

Studies at this site

• VE303 for Prevention of Recurrent Clostridioides Difficile Infection — Recruiting now
• HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial — Recruiting now
• An Efficacy and Safety Study of APX001 in Non-Neutropenic Patients With Candidemia — Completed
• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed
• A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria. — Completed
• An Adult Spasticity Registry of OnabotulinumtoxinA Treatment — Completed